Tirzepatide 15mg Vials - 99.9% Pure Diabetes Research Compound

Tirzepatide 15mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for metabolic research applications. This synthetic peptide compound (LY3298176) demonstrates superior stability and biological activity in preclinical studies.

Our pharmaceutical grade Tirzepatide 15mg is manufactured under strict GMP conditions, ensuring consistent quality and purity exceeding 99.9%. The product is supplied in sterile vials suitable for research use only, with comprehensive analytical documentation including HPLC and MS spectra.

The molecular structure (C225H348N48O68) has been carefully characterized with a molecular weight of 4813 g/mol. Each batch undergoes rigorous quality control testing to verify identity, purity, and biological activity before release.

As a professional manufacturer, we offer flexible supply options including small-scale batches for preliminary research and large-volume production for clinical studies. Custom formulations and packaging solutions are available to meet specific project requirements.

All Tirzepatide 15mg products are strictly for research purposes and not intended for human consumption. Researchers should handle this material according to appropriate laboratory safety protocols.